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Abstract
Previous genome-wide association studies among women of European ancestry identified two independent breast cancer susceptibility loci represented by single nucleotide polymorphisms (SNPs) rs13281615 and rs11780156 at 8q24. We conducted a fine-mapping study across 2.06 
Introduction
Breast cancer is one of the most common malignancies among women worldwide. 1 Genomewide association studies (GWASs) have identified approximately 100 loci associated with breast 2 cancer. Multiple independent variants on 8q24 have been shown to confer susceptibility for 3, 4 multiple types of cancer, including breast, prostate, colorectal, bladder, ovarian, renal cell, 5 glioma, chronic lymphocytic leukemia, and Hodgkin's lymphoma, (also see Supplementary Figure S1 ). Although most of these loci are located in a "gene desert" region, several hundred kilobases (kb) telomeric to several genes including FAM84B, POU5F1B, MYC, and the long non-coding gene PVT1. A growing number of studies have shown that the 8q24 locus may 6 harbor long-range regulatory elements involved in regulating expression of the MYC or PVT1 7 genes.
In most GWAS, only the single nucleotide polymorphism (SNP) showing the strongest statistical association at each locus (hereinafter referred to as the index SNP) is reported. Those index SNPs themselves are usually not the causal variants but are in linkage disequilibrium (LD) with the functional variants. In addition to the common variants identified by GWAS, low-8 frequency variants in susceptible loci may also be associated with disease risk. Furthermore, in each locus, there may exist allelic heterogeneity and multiple independent variants that may be 8 associated with complex diseases. Some of the missing heritability for disease may be derived from the incomplete coverage of genetic variants and poor representation of the full spectrum of 9, 10 causal variants on commercial genotyping arrays. Therefore, it is necessary to conduct finescale mapping studies to investigate comprehensively all genetic variants in the LD blocks where a GWAS index SNP is located.
We conducted a fine-mapping study of the 8q24 region using data from 106,708 individuals within the Breast Cancer Association Consortium (BCAC). We systematically evaluated the associations with breast cancer risk of the SNPs across 2.06 Mb in this chromosome region. We aimed to identify additional independent association signals and potentially functional variants that may be responsible for the observed associations of variants in this locus with breast cancer risk.
Materials and Methods

Ethics statement
All studies were approved by the relevant institutional review committee and informed consent was obtained from all participants.
Subjects
Epidemiological and genotype data were obtained from 50 breast cancer case-control studies 4 participating in the BCAC. The sample set for the current project included 48,155 cases and 43,612 controls of European ancestry from 39 studies, 6,269 cases and 6,624 controls of Asian ancestry from 9 studies, and 1,116 cases and 932 controls of African ancestry from 2 studies.
The estrogen receptor (ER) status of the primary tumor was available for 35,824 cases of European ancestry; 28,038 (78%) cases were ER+ and 7,786 (22%) were ER-.
SNP selection and genotyping
Fine-mapping SNPs were selected for inclusion on the custom Illumina iSelect array 4, [11] [12] [13] (iCOGS to be 1.8 for breast cancer. All analyses were conducted using R version 3.0.1.
Functional annotation
We annotated a total of 245 breast cancer risk associated variants (P<10 -4 from univariate analysis) for potential functional significance using data from the Encyclopedia of DNA Elements (ENCODE), the Roadmap Epigenomics Mapping Consortium, and The Cancer Genome Atlas (TCGA) (see URLs). For each variant, we investigated whether it is mapped to transcriptional elements primarily associated with enhancers (H3K4me1) or promoters (H3K4me3), in any of nine cell lines: normal human mammary epithelial cell line (HMEC), GM12878, H1-hESC, K562, HepG2, HSMM, HUVEC, NHEK, and NHLF. The epigenetic landscape of histone markers H3K4Me1, H3K4Me3, and H3K27Ac was also examined through layered histone tracks on seven ENCODE cell lines, including GM12878, H1-hESC, K562, HSMM, HUVEC, NHEK, and NHLF from the UCSC Genome Browser (see URLs). DNase I hypersensitive and transcription factor (TF) ChIP-Seq datasets were investigated in all available ENCODE cell lines, including HMEC and the breast cancer cell lines T-47D and MCF-7. 15 16 Publicly available tools RegulomeDB and HaploReg v4.1 were also used to evaluate potential functional variants.
For regions lacking ChIP-seq peaks data, we collected raw ChIP-seq data for the estrogen receptor-(ESR1) and forkhead box protein A1 (FOXA1) in MCF-7, TAMR and ZR751 breast and only the top 5% of peaks were selected for motif discovery. The summits of the top 5% peaks were extended by 100 bp on either side. Similar methodological strategy has been used 21, 22 elsewhere. Motifs between 5 and 30 bp in length were identified on both strands. We employed the MEME 4.9.1 toolkit to search DNA motifs and enrichment significance for ESR1 and FOXA1.
Expression quantitative trait (eQTL) analysis 24 eQTL analysis was performed followings the method described previously. Briefly, RNA-Seq V2 data (level 3) of 1,006 breast cancer tumor tissues were downloaded from the TCGA data portal (see URLs). DNA methylation data measured by the Illumina HumanMethylation450
BeadChip and genotype data from the Affymetrix SNP 6.0 array were also retrieved from TCGA level 3 data. Genotype data of the flanking 2 Mb region of the index SNPs on 8q24 were extracted and then imputed to the 1000 Genomes Project data with Minimac (see URLs). Only common SNPs (MAF > 0.05) with high imputation quality (r 2 > 0.3) were included in the present study. For the interrogated 2 Mb region, copy number variation (CNV) data spanning the 8q24 genes FAM84B, POU5F1B, MYC, and PVT1 from TCGA tumor tissue samples were collected from the CbioPortal (see URLs).
We used the TCGA breast cancer data described above to perform cis-eQTL analyses in tumor tissues. Several steps were taken to reduce the batch and other technical effects on gene 
Results
Associations with breast cancer risk among women of European ancestry
We first conducted univariate analysis for 2,391 genotyped and 4,240 well-imputed SNPs in samples from women of European ancestry. A total of 359 SNPs were associated with breast cancer risk with a statistical significance of P < 10 -4 ( Figure 1 and Supplementary Table S2 ).
Confirming previous GWAS results, the index SNPs rs13281615 (Signal 2 in Table 1 ) and rs11780156 (Signal 5 in Table 1 ) showed significant associations with ORs of 1.11 (95% CI = and rs11780156 were forced into the model, we found two additional independent association signals at statistical significance of P < 1 × 10 -4 and a third one with suggestive evidence (P = 1.1× 10 -4 ) ( Table 1 and Supplementary Figure S2 ). The first independent signal (Signal 1 in Table 1 Figure S2) . No significant evidence of between-study heterogeneity was observed for any of these independently risk-associated SNPs (data not shown).
Stratified by ER status, all five independent signals showed significant associations for ER+ breast cancer; however, with the exception of rs11780156 showing a P value of 0.012 (signal 5), no significant associations were observed for ER-breast cancer (Table 2) .
Haplotype analyses were performed using data from the five independent risk signals ( Table   3 ). In women of European ancestry, a total of 16 haplotypes with frequency of > 1% were observed. Compared to the reference haplotype, which carries the alleles associated with a reduced risk in all five SNPs, most haplotypes were associated with increased breast cancer risk.
Haplotype 5, which carries the risk-associated alleles of the signals 1-3, showed the most significant association (P = 3.4 × 10 -11 for overall breast cancer) while Haplotype 1, which carries the risk-associated alleles of all signals except for Signal 4, was associated with the highest estimated OR (OR = 1.27, 95% CI = 1.15-1.39 for overall breast cancer) ( Table 3 ). As shown in Table 3 , similar haplotype associations were observed for ER+ but not for ER-breast cancer.
Association with breast cancer risk in women of Asian or African ancestry
Of the five independently risk-associated variants identified in women of European ancestry, only rs35961416 (Signal 1) showed a nominal association in African-American women at P < 0.05 (P = 0.04, Table 4 ). Based on univariate analyses of all SNPs on 8q24 that passed QC, SNP rs76382129 showed a P value of 8.3 × 10 -4 in women of Asian ancestry and five SNPs showed P values of between 9.6 × 10 -4 and 1.6 × 10 -4 in women of African ancestry (Supplementary Table   S3 ). Another 16 SNPs showed breast cancer risk association with P values between 0.01 and 0.001 in either population and in the same direction across the two populations (Table 4) .
Functional annotation
For each of the five independent signals identified among women of European ancestry, we Tables S4-S6) . Thus, a total of 245 unique SNPs including the five representative SNPs in five signal regions were further evaluated for their potentially functional significance.
Our integrative functional annotation from ENCODE, Roadmap Epigenomics, the 15 16 RegulomeDB , the HaploReg databases , and other public data identified the representative Table S7 ).
Discussion
In this study, we conducted a fine-mapping investigation at the breast cancer susceptibility locus on 8q24. Among women of European ancestry, we identified four independent association signals represented by rs35961416, rs13281615, rs7815245 and rs11780156, respectively, and The most attractive candidate gene for cancer risk variants in the gene-desert 8q24 region is the proto-oncogene MYC, because it plays a vital role in tumorigenesis and metastasis of several [31] [32] [33] types of cancer including breast cancer. As a key transcription factor, MYC forms heterodimers with MAX, and then regulates transcription of genes involved in cell growth, and 31 proliferation. Aberrant MYC signaling can promote cell transformation and tumor 32, 33 progression. Although most of the GWAS-identified SNPs on 8q24 for multiple types of 5, 34 cancers are not mapped to the MYC genic region, they may cis-regulate nearby genes 5 including MYC and its 53-kb downstream non-coding gene PVT1. For example, cancer riskassociated variants may regulate MYC expression by forming a large chromatin loop with the 6, 26, 35 MYC locus. This hypothesis has been partially supported by the fact that trait-associated loci 26, 36, 37 are frequently found to be cis-eQTL. Our e-QTL analysis of the TCGA breast cancer tumor tissues showed a trend that rs1121948 in Signal 5 might affect MYC or PVT1 expression levels 38 (Supplementary Table 7) , consistent with a co-expression pattern. However, the risk-increased alleles are associated with down-regulated gene expression of MYC or PVT1. This is inconsistent [39] [40] [41] [42] with overexpression of these two genes commonly observed in breast cancer tumors, leaving challenges to link the risk alleles and the possible candidate gene(s) in malignancy.
Of the five independent association signals observed among women of European ancestry, only rs35961416 showed a significant association in women of African ancestry. This could be due to small effect size, different allele frequency, or allelic heterogeneity by race. Differences in GWAS findings across populations have commonly been observed for breast cancer and many [43] [44] [45] other complex traits.
Taking the GWAS index SNP rs13281615 as an example, the risk allele for any of the putative functional SNPs implicated in our study, preventing us from drawing a more definitive conclusion regarding the functionality of these variants. For example, our in silico analyses suggest that rs1121948 is located in binding sites of GATA3 and MAX, which may regulate MYC expression, but such potential interaction needs to be demonstrated [47] [48] [49] [50] experimentally. Second, we limited our investigation to variants with a MAF > 0.02, and thus it is possible that some rare variants in these loci may also contribute to the risk of breast cancer.
In conclusion, our fine mapping study identified two additional and another suggestive independent association signals on 8q24 among women of European ancestry, which together with two previous reported GWAS index signals plain approximately 0.55% of excess familial risk of breast cancer. In addition, our functional analyses revealed two putatively functional variants that can be further investigated experimentally. Our study provides additional evidence of the importance of common independent variants on 8q24 in breast cancer susceptibility. 
